Survodutide

Newest Survodutide Information

Survodutide Peptide: The Complete Guide - Uses, Mechanism, Dosing, Safety & Research

Survodutide (also spelled survodutide; development code BI 456906) is an acylated synthetic peptide that simultaneously activates two metabolic hormone receptors: the GLP-1 receptor and the glucagon receptor. It is currently in Phase 3 clinical trials for obesity, type 2 diabetes, and metabolic liver disease. Phase 2 human trial data shows up to 18.7% mean body weight reduction and biopsy-confirmed improvements in liver fibrosis. This guide covers what the survodutide peptide does, how its dual-receptor mechanism works, what the clinical research shows, how it is administered, its safety profile, and its current investigational status.

Survodutide 29 min read

dont Spend six hours researching every peptide.

About MyPeptidePal

MyPeptidePal is the world's largest peptide knowledge base and your personal AI peptide expert in one. Trained on every published study and over 10,000 protocols, it gets smarter every day, learning from new research and a community actively running and tracking their own. Build a personalized protocol in 60 seconds, get dosing math you can trust, find vetted suppliers, set auto-pilot reminders, and get straight answers on peptides, health, fitness, and longevity, all in one place. Try for FREE Here, no credit card required.